Preventive actions - COVID-19
Out of concern for the safety of our employees and health of patients, the Management Board of Biofarm has decided to introduce various preventive measures designed to minimize the risk of spreading SARS-CoV-2 virus.
Ginkofar® awarded the consumer quality leader title
Ginkofar® has enjoyed the confidence of patients for over 20 years. It is the undisputed market leader, which is also confirmed by the title of the 2019 consumer quality leader. Biofarm’s strategic focus is on providing products of high quality, therefore, this award make us particularly happy.
Biotynox® is the consumer quality leader!
Biotynox® has been awarded the consumer quality leader in the 2019 debut category. We are very pleased that our work is appreciated and noticed by patients.
Once again this year, we are launching new OTC medicines
This month, our brand new OTC medicines - Magnefar® B6 Forte and Magnefar® B6 Bio arrived at pharmacies in Poland. This is yet another success of Biofarm, responding to the needs of patients who suffer from fatigue, cramps and other symptoms of magnesium deficiency.
Unique dose of Nebivolol – 10 mg
Hypertension is the most important modifiable risk factor for cardiovascular diseases, and according to WHO is also the major cause of premature death in the world. Based on the NATPOL and WOBASZ II studies, it is estimated that currently in Poland hypertension affects 11 million patients, and by 2035 their number may increase by up to half.